Viking Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
/ 
Frequently asked questions
To buy Viking Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Viking Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Viking Therapeutics Inc. is VKTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Viking Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Viking Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Viking Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Viking Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Viking Therapeutics Inc..